Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties

ConditionsPost Operative Pain Anesthesia Nerve Block Shoulder Osteoarthritis

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18-90

SponsorMelinda Seering

About this trial

Comparison of post-operative pain after total shoulder surgery. The Principle Investigator will be comparing Exparel single shot block to Interscalene catheter

Eligibility criteria

Qualifiers

Orthopedics service patients having reverse shoulder replacement surgery

ASA class I, II, or III.

Patients at least 18 years old but less than 90 years old.

Patients giving informed consent.

Disqualifiers

An inability to cooperate during the block placement.

Patients who do not meet criteria for a regional block: such as those on anti-coagulation,

Significant pulmonary disease or allergy to medications used for peripheral nerve blocks (Exparel, Bupivacaine and Ropivacaine)

Neuropathy of the planned extremity to block

Trial design

Treatments tested in this trial

Interscalene Catheter
Exparel Single Shot Interscalene Block

Treatment groups

56 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Melinda Seering

Lead sponsor

University of Iowa

Sponsor institution

Source ClinicalTrials.gov